What biologics would you use in a patient with rheumatoid arthritis who developed multiple basal cell carcinomas (requiring Mohs surgery) while on a TNF-inhibitor and did not respond to rituximab?

Would you switch to a biologic with a different mechanism of action and if so, what options would you consider?